20 recalls found for Chlorpromazine Hydrochloride. Check if any of your products are affected.
Major Pharmaceuticals recalled 2,064 blister packs of Chlorpromazine Hydrochloride Tablets on September 12, 2025. The recall follows the discovery of N-Nitroso Desmethyl Chlorpromazine exceeding safe limits. Consumers must stop using this product immediately and consult healthcare providers for guidance.
Major Pharmaceuticals announced a recall of 1,256 blister packs of Chlorpromazine Hydrochloride Tablets on September 12, 2025. The recall stems from the presence of N-Nitroso Desmethyl Chlorpromazine above safe intake levels. Consumers must stop using the product immediately and contact their healthcare provider for guidance.
Major Pharmaceuticals recalled 506 blister packs of Chlorpromazine Hydrochloride tablets on September 12, 2025. The recall stems from CGMP deviations due to the presence of N-Nitroso Desmethyl Chlorpromazine above safe limits. Consumers should stop using the product immediately and consult healthcare providers.
Major Pharmaceuticals recalled 1,394 blister packs of Chlorpromazine Hydrochloride Tablets due to contamination concerns. The recall occurred on September 12, 2025, after the FDA found N-Nitroso Desmethyl Chlorpromazine above acceptable limits. Consumers should stop using these tablets and seek guidance from healthcare providers.
Major Pharmaceuticals recalled 866 blister packs of Chlorpromazine Hydrochloride Tablets on September 12, 2025. The recall follows the detection of N-Nitroso Desmethyl Chlorpromazine above safe limits. The affected products were distributed nationwide and are classified as a Class II hazard.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The tablets exceed the acceptable limit for N-Nitroso Desmethyl Chlorpromazine. This recall affects the nationwide distribution in the USA.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride tablets on September 3, 2025. The recall affects tablets manufactured in India with high levels of a hazardous chemical. Consumers must stop using the product immediately and contact their healthcare provider.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 100-count bottles of 50 mg tablets due to excessive levels of N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and contact health providers for guidance.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects a specific lot due to contamination with N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 25 mg tablets due to high levels of N-Nitroso Desmethyl Chlorpromazine. Consumers must stop using the product immediately.
American Health Packaging recalled 2,708 cartons of Chlorpromazine Hydrochloride Tablets on August 27, 2025. The recall follows the detection of a micro-organism in product packaging, though no contamination was found on the tablets themselves.
American Health Packaging recalled 1,062 cartons of Chlorpromazine Hydrochloride Tablets on August 27, 2025. The recall stems from the detection of a micro-organism in auxiliary packaging materials. No micro-organism was found on the tablets themselves, but consumers should stop using the product immediately.
American Health Packaging recalled 1,757 cartons of Chlorpromazine Hydrochloride Tablets on August 27, 2025. The recall stems from the detection of a microorganism in packaging materials, though no contamination was found on the tablets themselves. Consumers should stop using the product immediately and contact healthcare providers for guidance.
American Health Packaging recalled 873 cartons of Chlorpromazine Hydrochloride Tablets on August 27, 2025. The recall stems from the presence of a micro-organism in packaging material. No micro-organisms were found on the tablets themselves.
AvKare recalled 2,003 cartons of Chlorpromazine Hydrochloride Tablets on August 25, 2025. The recall stems from the presence of a foreign substance in the medication. Consumers should stop using the product immediately and seek guidance from healthcare providers.
AvKare recalled 1,512 cartons of Chlorpromazine Hydrochloride Tablets on August 25, 2025. The recall follows the discovery of a foreign substance in the medication. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Amneal Pharmaceuticals recalled 3,363 bottles of Chlorpromazine Hydrochloride Tablets on August 18, 2025. The recall stems from the presence of a microorganism in packaging material. No microorganisms were detected in the tablets themselves, but consumers should stop using the product immediately.
Amneal Pharmaceuticals recalled 7,228 bottles of Chlorpromazine Hydrochloride Tablets on August 18, 2025. The recall occurred due to the presence of a micro-organism in the packaging material. No micro-organisms were found on the tablets themselves.
Amneal Pharmaceuticals recalled 14,923 bottles of Chlorpromazine Hydrochloride Tablets on August 18, 2025. A specific lot of polyester coil used in product packaging tested positive for a micro-organism. No contamination was found in the tablets themselves.
Amneal Pharmaceuticals recalled 13,130 bottles of Chlorpromazine Hydrochloride Tablets on August 18, 2025, due to contamination concerns. The recall affects specific lots identified by their lot numbers AM240147, AM240148, AM240664, and AM240665. Consumers should stop using the tablets immediately and contact their healthcare provider for further guidance.